Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas

Although various anti-cutaneous T-cell lymphoma (CTCL) therapies are available for clinical use, appropriate chemotherapy lines for the treatment of CTCLs have yet to be established. Therefore, to date, various clinical trials for the treatment of advanced CTCLs are ongoing. In this review, we evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Amagai, Ryo, Kambayashi, Yumi, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913115/
https://www.ncbi.nlm.nih.gov/pubmed/33540765
http://dx.doi.org/10.3390/pharmaceutics13020200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913115/
https://www.ncbi.nlm.nih.gov/pubmed/33540765
http://dx.doi.org/10.3390/pharmaceutics13020200

Ejemplares similares